Note: Ingredients listed on restricted chemical lists
EC/CAS
8052-41-3
Name of the chemical
Stoddard Solvent; Naphtha (petroleum), hydrodesulfurized heavy
Concentration
N/A
General Information
Revision date
2007-09-03
Product name
Chromatic Bulletin Colors (including 4010021 through 4010195)
Product Synonyms
Carbon black
Chemical name
Chromatic Bulletin Colors (including 4010021 through 4010195)
CAS No.
8052-41-3
1.2.1 Relevant identified uses
THE ITEMS LISTED BELOW ARE NOT CONTAINED IN ALL COLORS. SEE THE TABLE ON PAGE 2 TO DETERMINE WHICH COLORS CONTAIN THESE INGREDIENTS AND % WT 1,3,5-Trimethylbenzene
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
A Spraylat Company
e-mail address of the competent person responsible for the Safety Data Sheet
HSEcoordinator@Spraylat.com
Section 2
SECTION 2: Hazards identification
OSHA HMIS HEALTH 2 * 0 = Least 1 = Slight 2 = Moderate 3 = High 4 = Extreme FLAMMABILITY 2
Potential chronic health
REACTIVITY 0 v5.3 Page 1 of 6 6 the of OTHER ASTM CARCINOGENICITY Yes No No No No No No only) * * * by 2 * * * * * * Page approved NTP method (IARC, BENZIMIDAZOLONE equivalent <10 < < 5 5 No No No 1 5 5 5 5 5 COMPOUND(S) % < < < <40 < < < % or Weight CAS# 14808-60-7 1309-37-1 1332-58-7 471-34-1 8032-32-4 64742-82-1 24 Method TS162510583 1,3,5-TRIMETHYLBENZENE -- 1 1 1 1 1 1 1 1 1 1 1 Reference < < < < < < < < < < < COLORS No No No EPA Heavy of Compounds NICKEL ANTIMIONY TITNAIUM RUTILE & calculations INGREDIENT Silica 5 5 5 5 Carbonate Spirits Hydrodesulfurized < < < < No No No Azo the BULLETIN LIGHT AROMATIC SOLVENT NAPHTHA < and Oxide No No No 5 OTHER Crystalline Iron Kaolin Calcium Petroleum Benzimidizolone Naphtha, 5 inks and CHROMATIC BARIUM SULFATE PRODUCT# 4010108 4010124 4010140 4010156 No No No coatings 5 5 5 < < < adhesives, OF for XYLENE 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 solvents, < < < < < < < < < < < < < < < < < < < < < < < < < < < < No No No INGREDIENTS ALIPHATIC only) water NTP exempt (IARC, NAPHTHA CARCINOGENICITY No Yes No No No No No and 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 SOLVENT < < < < < < < < < < < < < < < < < < < < < < < < < < < < No No No (PETROLEUM) MED. less % <40 < <10 < < <40 < 1 5 5 5 basis, ADDITIONAL <30 <30 <30 < <15 <10 <10 <10 < < <10 < <10 < < < <15 <15 <10 <25 14808-60-7 14807-96-6 10361-37-2 10361-37-2 471-34-1 8001-26-1 solids CAS# 471-34-1 TITANIUM DIOXIDE percent a Ingredients: 5 5 5 5 5 5 5 Yes No No INGREDIENT Carbonate Silica Chloride Chloride Carbonate using CARBON BLACK < < V.O.C.‡ LBS/GL 3.4 2.9 3.8 3.1 2.9 3.7 3.3 3.2 3.3 3.5 3.4 3.2 3.5 4.0 2.9 4.4 3.7 3.7 3.1 3.6 3.3 3.5 3.3 3.4 3.3 3.2 3.3 3.3 3.4 3.6 2.9 < < < Yes No No by determined Additional 5 5 1 Oil IARC NTP OSHA OTHER Calcium Crystalline Talc Barium Barium Calcium Linseed DENSITY LBS/GL content office. Other is 7.8 9.6 12.2 10.0 10.2 9.4 9.2 8.1 8.3 8.9 8.9 10.1 10.5 11.4 8.9 11.3 10.3 9.1 8.3 9.0 8.4 8.7 8.2 8.4 8.1 8.4 8.3 8.7 8.8 8.0 9.9 PRODUCT# 4010021 4010021F 4010100 4010101 4010101SW 4010102 4010104 4010106 4010108 4010114 4010115 4010116 4010124 4010130 4010132 4010134 4010140 4010142 4010143 4010144 4010148 4010150 4010152 4010153 4010156 4010158 4010162 4010163 4010164 4010166 4010195 of Carcinogenicity: ‡ * VOC The executive List PRODUCT# 4010021F 4010100 4010102 4010106 v5.3 Routes of Entry: Inhalation, Absorption.
Medical Conditions Generally Aggravated by Exposure
Eye disease, Skin disease including eczema and sensitization, Kidney disease, Liver disease, Lung disease. Immediate (Acute) Health Effects: Inhalation: Can cause moderate respiratory irritation, dizziness, weakness, fatigue, nausea and headache. Skin Contact: Can cause minor skin irritation, defatting, and dermatitis. Eye Contact: Can cause moderate irritation, tearing and reddening, but not likely to permanently injure eye tissue. Skin Absorption: Skin absorption may be a significant source of exposure. Ingestion: Harmful if swallowed. May cause systemic poisoning. Can cause abdominal discomfort, nausea, vomiting and diarrhea. Aspiration of material into the lungs can cause chemical pneumonitis. Target Organ Acute Toxicity: Eyes, Skin, Respiratory System, Kidneys, Nervous System, Liver, Thyroid, Pituitary, Testes. Long-Term (Chronic) Health Effects: Inhalation: Upon prolonged and/or repeated exposure, can cause moderate respiratory irritation, dizziness, weakness, fatigue, nausea and headache. Skin Contact: Upon prolonged or repeated contact, can cause moderate skin irritation, defatting, and dermatitis. Not likely to cause permanent damage. Eye Contact: Upon prolonged or repeated contact, can cause moderate irritation, tearing and reddening, but not likely to permanently injure eye tissue. Skin Absorption: Upon prolonged or repeated exposure, harmful if absorbed through the skin. May cause severe irritation and systemic damage. Carcinogenicity: See Table on page 2. Target Organ Chronic Toxicity: Nervous System, Eyes, Skin, Respiratory System, Kidneys, Liver, Pituitary, Testes. NOTICE - Reports have associated repeated and prolonged occupational overexposure to solvents with brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents may be harmful or fatal. Lifetime inhalation exposure of rats and mice to high concentrations of ethylbenzene (750 ppm) resulted in increases in certain types of cancer, including kidney, lung and liver tumors. Testicular adenomas were increased as were thyroid effects in rats at 750 ppm. Pituitary effects were observed in female mice at 250 ppm. These effects were absent when exposure was below 75 ppm ethylbenzene. The study does not address the relevance of these results to humans. IARC has recently re-evaluated titanium dioxide as possibly carcinogenic to humans (Group 2B) based on animal studies. However, human studies available to date do not suggest that occupational exposure to titanium dioxide increases cancer risk. The ACGIH classifies titanium dioxide as A4 (not classifiable as a human carcinogen). NTP does not classify it as carcinogenic. IARC's evaluation shows inadequate evidence of carcinogenicity in humans, but sufficient evidence of carcinogenicity in experimental animals. The evidence shows that high concentrations of powdered and ultrafine titanium dioxide dust caused respiratory tract cancer in rats exposed by either natural inhalation or direct introduction into the lungs. However, the same results are observed in people working in dusty environments. Therefore, IARC extended this idea to workers with exposures to titanium dioxide dust, if there are insufficient dust control measures in place. Based on the IARC decision, Canadian officials have agreed that titanium dioxide is classifiable as WHMIS D2A (carcinogen), and that it is not necessary to wait for release of the full monograph. OSHA requires the status on US MSDSs to change within 90 days of publication in the IARC monograph volume 93. Products 4010021F and 4010108 contain Crystalline Silica (see List of Other Additional Ingredients, page 2): Cutting, sanding or grinding dried or cured material may release particles of crystalline silica (quartz). Exposure to airborne particles may cause lung damage including a risk of cancer. Chronic exposure may result in chest pain, difficulty breathing, lung damage and silicosis. (Silicosis is the permanent deposition of silica in lung tissue that results in lung damage.) There may exist a relationship between silicosis and certain cancers. Some products contain pigments which may become a dust nuisance when removed by abrasive blasting, sanding or grinding. See Section II. v5.3 Page 3 of 6 IV. FIRST AID Inhalation: Remove to fresh air. If breathing is difficult, have a trained individual administer oxygen. Seek medical attention if symptoms persist.